Clinical Trial Update: Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Adebrelimab as perioperative therapy for locally advanced gastric or gastroesophageal junction cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Conditions: Locally Advanced Gastric or Gastroesophageal Junction Cancer | Phase 3 | Status: NOT_YET_RECRUITING